-
Targets of MEK inhibition in DIPG
Study
EGAS00001004495
-
Uterine leiomyoma: DNA methylation, chromatin activity and gene expression
Study
EGAS00001004499
-
DNA methylation and somatic mutations converge on cell cycle and define similar evolutionary histories in brain tumors
Study
EGAS00001001255
-
Search for new loci and low-frequency variants influencing glioma risk by exome-array analysis
Study
EGAS00001001258
-
Phylogenetic evolution of metastatic melanoma.
Study
EGAS00001003582
-
Deciphering the mutational landscape and the genome organization of LMS
Study
EGAS00001001262
-
Integrated molecular analysis of adult T-cell leukemia/lymphoma
Study
EGAS00001001296
-
Genomic characterization of esophageal squamous cell carcinoma reveals critical genes underlying tumorigenesis and poor prognosis
Study
EGAS00001001723
-
Growth Hormone (GH) -secreting Pituitary Adenoma
Study
EGAS00001001293
-
Clonal selection and double hit events involving tumor suppressor genes underlie relapse from total therapy
Study
EGAS00001001810
-
Tumor-derived cell lines as pharmacogenomic models to predict therapeutic vulnerabilities in hepatocellular carcinoma
Study
EGAS00001003536
-
Targeting FGFR1 for treatment of soft-tissue sarcoma (H021)
Study
EGAS00001001844
-
RNA-sequencing of adult T-cell leukemia/lymphoma samples
Study
EGAS00001003575
-
Cancer-Associated Mutations in Endometriosis without Cancer
Study
EGAS00001003576
-
Transcriptomic analysis of the Phase 3 COMPARZ clinical trial
Study
EGAS00001004534
-
Multiomic profiling of early-passage melanoma cell lines.
Study
EGAS00001004536
-
Multi-omics analysis of primary glioblastoma cell-lines shows recapitulation of pivotal molecular features of parental tumors
Study
EGAS00001001871
-
Whole-exome sequencing of hepatocellular carcinoma biopsies (proteogenomic study)
Study
EGAS00001005073
-
Carcinoma of the oral tongue (OTSCC) genomic landscape characterisation
Study
EGAS00001001329
-
Clinical relevance of somatic copy-number alterations in plasma circulating tumor DNA from advanced EGFR-mutated NSCLC patients treated with osimertinib
Study
EGAS00001004539
-
A somatic reference standard for cancer genome sequencing with COLO829
Study
EGAS00001001385
-
MGMT genomic rearrangements contribute to chemotherapy resistance in gliomas
Study
EGAS00001004544
-
Survival Benefit and Genetic Profile of Pemetrexed as Initial Chemotherapy in Selected Chinese Patients with Advanced Lung Adenocarcinoma
Study
EGAS00001004546
-
Glioblastoma_CRISPR_Screen
Study
EGAS00001001519
-
A Multifactorial Tumor and Immune Cell Profile Determines Response to Immune Checkpoint blockade in Melanoma
Study
EGAS00001004548
-
A comprehensive assessment of somatic mutation detection in cancer using whole genome sequencing
Study
EGAS00001001539
-
Whole genome sequencing of primary and metastatic Melanoma cases in an Australian cohort.
Study
EGAS00001001552
-
PSCP_mutation_analysis_in_hESCs
Study
EGAS00001001561
-
Mutational landscape of renal cell carcinoma with venous tumor thrombus
Study
EGAS00001001950
-
Super enhancers define regulatory subtypes and cell identity in neuroblastoma
Study
EGAS00001004551
-
The genomic landscape of germinal center derived B-cell lymphomas other than follicular, diffuse-large B-cell and Burkitt lymphom
Study
EGAS00001002422
-
Integrated genomic characterization of IDH1 mutant Glioma malignant progression
Study
EGAS00001001588
-
Malignant pheochromocytomas/paragangliomas harbor mutations in transport and cell adhesion genes
Study
EGAS00001001601
-
Super enhancers define regulatory subtypes and cell identity in neuroblastoma - RNA-seq
Study
EGAS00001004552
-
A Phase II Trial of High Dose Interleukin-2 and Multi-site Stereotactic Ablative Radiotherapy for Patients with Metastatic Renal Cell Carcinoma
Study
EGAS00001003605
-
Identifying_Novel_Fusion_Genes_in_Myeloma
Study
EGAS00001000220
-
Recapitulation of genetic predisposition to medulloblastoma in human neuroepithelial stem cells
Study
EGAS00001003620
-
Whole-genome landscape of adult T-cell leukemia/lymphoma
Study
EGAS00001005237
-
SCAT_osteosarcoma_sequencing
Study
EGAS00001000196
-
RNASeq of PDX and CDX tumours treated with ADC
Study
EGAS00001004562
-
Clinical Outcomes by Tumor Mutational Burden and Inflammatory Gene Expression With Combined Nivolumab and Ipilimumab or Monotherapy in Advanced Melanoma
Study
EGAS00001004564
-
Clinical Outcomes by Tumor Mutational Burden and Inflammatory Gene Expression With Combined Nivolumab and Ipilimumab or Monotherapy in Advanced Melanoma - CM066-WES
Study
EGAS00001004567
-
BLUEPRINT DNA Methylation 450K data of mantle cell lymphoma
Study
EGAS00001001637
-
Spatial and Temporal Homogeneity of Driver Mutations in Diffuse Intrinsic Pointine Glioma
Study
EGAS00001001654
-
33 patients with Monoclonal Gammopathy of Undetermined Significance (MGUS) had whole exome sequencing performed. Cells were sorted by FACSAria using CD138, CD19 and CD56 to obtain a pure abnormal plasma cell population. Generated somatic variants were compared to a previous study of 463 multiple myeloma patients.
Study
EGAS00001001658
-
Paired exome analysis in urothelial carcinoma
Study
EGAS00001001686
-
Whole exome sequencing on primary retinoblastoma tissues and matching lymphocyte DNA.
Study
EGAS00001001690
-
Histological Transformation and Progression in Follicular Lymphoma: a Clonal Evolution Study
Study
EGAS00001001709
-
Pilot study for Illumina TST170 NGS panel on cutaneous T cell lymphoma samples
Study
EGAS00001002567
-
Single-cell RNA sequencing on 5063 single T cells isolated from peripheral blood, tumour and adjacent normal tissues from six hepatocellular carcinoma patients.
Study
EGAS00001002072